Excipients...the good, the bad and the ugly
| Educator
21st Feb, 2020Article

This post is specifically for health practitioners. Create a free account

Alternatively, view general public info.

Learn more about vital.ly

Excipients - hub Essentials

Excipients... The good, the bad and the ugly

The word excipient is derived from the Latin excipere, meaning 'to except', which is simply explained as 'other than'. Excipients are everything 'other than' the active ingredient. Excipients are usually considered inert, however, it is currently being recognised that an excipient’s direct interaction with the active ingredient is not negligible. Research has shown the ability of excipients to react with other ingredients in the formulation and cause adverse and hypersensitivity reactions in patients (1).

Excipients may make up to 90% of a product formulation (1) and may be synthetic or sourced from plants or animals.

Considerable ingenuity and formulation expertise are required to produce a supplement that will be stable during storage, transport and handling, yet will release its active ingredient as required once ingested (1).

Excipients selected for product formulation vary across the pharmaceutical and complementary medicine industries. The role of the excipient should not be underestimated, particularly when it comes to generic pharmaceuticals. A number of pharmaceutical excipients are known to have side effects or contraindications (2).

Originator medicines and generic preparations have been shown to be bioequivalent and therefore substitutable, however, they may contain different excipients. The medical/healthcare community needs to be aware that a generic preparation containing an excipient which is not part of the originator preparation has the potential to cause problems in a patient who had no issues in tolerating the original preparation (3).

According to the Therapeutic Goods Administration (TGA), types of excipient ingredients include: a fragrance, flavour, preservative, printing ink, antioxidant, coating, binding agent, filler or an anticaking agent (4). The TGA states that sponsors of complementary medicines should ensure appropriate use of excipients in terms of their roles and quantities within a product formulation. Claims cannot be made for excipient ingredients (4).

Depending on the medication/supplement type, excipients may be nil to low. Powders and capsules generally require fewer excipients than tablets due to binding and coating ingredients required for a tablet.

Each excipient serves a specific purpose for the proper performance of the supplement dose and form, i.e. capsule, tablet, powder or liquid (5). Common functions of excipients include:

  • Improve bioavailability
  • Low allergy excipients
  • Nutrient function
  • Binding nutrients
  • Antimicrobial preservatives
  • Antioxidant
  • Sweetener
  • Coating and glazes
  • Disintegrant for maximal absorption
  • pH adjustment

Commonly used excipients are listed in Table 1. This is not an exhaustive list. Australia has limited some animal-derived excipients to those sourced from specified listed countries to address infection concerns (22).

Table 1. Commonly used plant based excipients

Excipients - hub Essentials Table 1

For a full summary sheet, including animal, mineral and synthetic based excipients, see the Excipients Summary Sheet.

 

Takeaway on Excipients

The risk/benefit ratio of using an excipient to simplify a formulation should be always evaluated on not only its effect on production and quality, but also its safety (38).

References
1Haywood, A., & Glass, B. (2011). Pharmaceutical excipients - where do we begin? Australian Prescriber, 34(4), 112–114.
2Fusier I, Tollier C, Husson MC: Medicines containing pharmaceutical excipients with known effects: a French review. Pharm World Sci PWS. 2003, 25 (4): 152-155. 10.1023/A:1024815412228.
3Dunne, S., Shannon, B., Dunne, C. et al. A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacol Toxicol 14, 1 (2013).
4Types of ingredients in listed and registered complementary medicines. TGA: https://www.tga.gov.au/types-ingredients-listed-and-registered-complementary-medicines Last accessed: 26th January 2020.
5Handbook of Modern Pharmaceutical Analysis. Jessica Cha, Joseph S. Ranweiler, in Separation Science and Technology. 2011.
6Food and Agriculture Organisation of the United Nations. http://www.fao.org/docrep/w6355e/w6355e0l.htm Last accessed 12th May 2018
7Cho SS, Samuel P. Food Applications and Health Benefits. CRC Press, 18 Jun. 2009 - Technology & Engineering.
8Deshmukh K, Chidambaram K. Biopolymer Composites With High Dielectric Performance: Interface Engineering. in Biopolymer Composites in Electronics, 2017.
9Rice starch. https://www.drugs.com/inactive/rice-starch-547.html Last accessed 1 June 2018.
10Jeon YH, Oh SJ, Yang HJ, Lee SY, Pyun BY. Identification of major rice allergen and their clinical significance in children. Korean Journal of Pediatrics. 2011;54(10):414-421.
11Bos, C. & Bolhuis, G. & Lerk, C. & Duineveld, C.. (1992). Evaluation of modified rice starch, a new excipient for direct compression. Drug Development and Industrial Pharmacy - DRUG DEVELOP IND PHARM. 18. 93-106.
12Study of Binding Efficiency of Tapioca Starch using Iornoxicam as a Model Drug. https://www.researchgate.net/publication/244993323_Study_of_Binding_Efficiency_of_Tapioca_Starch_using_Iornoxicam_as_a_Model_Drug
13Hofman DL, van Buul VJ, Brouns FJ. Nutrition, Health, and Regulatory Aspects of Digestible Maltodextrins. Crit Rev Food Sci Nutr. 2016;56(12):2091–2100.
14Whelan, W. J. ( 2004) The wars of the carbohydrates, Part 3: Maltose. IUBMB Life 56, 641.
15Kant R. Sweet proteins – Potential replacement for artificial low calorie sweeteners. Nutrition Journal. 2005;4:5.
16Ashwell M. Stevia, Nature’s Zero-Calorie Sustainable Sweetener: A New Player in the Fight Against Obesity. Nutrition Today. 2015;50(3):129-134.
17Kalman DS, Feldman S, Krieger DR, Bloomer RJ. Comparison of coconut water and a carbohydrate-electrolyte sport drink on measures of hydration and physical performance in exercise-trained men. Journal of the International Society of Sports Nutrition. 2012;9:1.
18Sahasrabudhe NM, Beukema M, Tian L, et al. Dietary Fiber Pectin Directly Blocks Toll-Like Receptor 2-1 and Prevents Doxorubicin-Induced Ileitis. Front Immunol. 2018;9:383. Published 2018 Mar 1.
19van Nieuwenhuyzen, W. and Tomás, M.C. (2008), Update on vegetable lecithin and phospholipid technologies. Eur. J. Lipid Sci. Technol., 110: 472-486.
20Kidd PM. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev.. 2009 Sep;14(3):226-46.
21Guad RS et al. Natural excipients. Publisher: Nirali Prakashan, 2006, ISBN 8185790604, 9788185790602.
22Page A et al. Choosing a medication brand: Excipients, food intolerance and prescribing in older people. Maturitas vol. 107, 103 – 109.
23World Health Organisation. Regional Office for the Eastern Mediterranean. 17th July 2001. http://www.immunize.org/talking-about-vaccines/porcine.pdf Last accessed 5th May 2018
24Amjad Z (ed). Calcium Phosphates in the Pharmaceutical Process Development Chapter, Jan 1998. Kluwer, The Netherlands.
25Silicon Dioxide – Colloidal. https://www.drugs.com/inactive/silicon-dioxide-colloidal-200.html last accessed 5th June 2018.
26Jensen WB. The Origin of the Names Malic, Maleic, and Malonic Acid.. J. Chem. Educ. 2007, 84, 6, 924.
27Søltoft-Jensen J, Hansen F. New Chemical and Biochemical Hurdles. Da-Wen Sun. Emerging Technologies for Food Processing. Academic Press, 2005, 387-416.
28Russell IJ et al. Treatment of fibromyalgia syndrome with Super Malic: a randomized, double blind, placebo controlled, crossover pilot study. 1995 May;22(5):953-8.
29The sodium bicarbonate-carbon dioxide system. How does the sodium bicarbonate-carbon dioxide system buffer the pH of cell culture medium? American type culture collection. March 2014. Internet. (Cited 18th July 2018). Available from: https://www.atcc.org/Global/FAQs/5/F/The%20sodium%20bicarbonate-carbon%20dioxide%20system-57.aspx.
30Yago MR, Frymoyer AR, Smelick GS, et al. Gastric reacidification with betaine HCl in healthy volunteers with rabeprazole-induced hypochlorhydria. Mol Pharm. 2013;10(11):4032–4037.
31GABA and Glycine. S. M. Paul. American College of Neuropsychopharmacology. CNS Discovery Research. Lilly Research Laboratories. Eli Lilly and Company. Indianapolis IN 46285. 2000.
32Singh DH, Roychowdhury SVP. A review on recent advances of enteric coating. IOSR Journal of Pharmacy. e-ISSN: 2250-3013, p-ISSN: 2319-4219, www.iosrphr.org Volume 2 Issue 6 Nov-Dec. 2012 PP.05-11.
33Bawa AS, Anilakumar KR. Genetically modified foods: safety, risks and public concerns-a review. J Food Sci Technol. 2013;50(6):1035–1046.
34Skocaj M et al. Titanium dioxide in our everyday life; is it safe?. Radiol Oncol. 2011;45(4):227–247.
35Rowe KS et al. Synthetic food colouring and behaviour: A dose response effect in a double-blind, placebo-controlled, repeated-measures study. The Journal of Pediatrics, 125(5), 691 – 698. 1994.
36Rangan C, Barceloux DG. Food additives and sensitivities. Dis Mon. 2009;55:292–311.
37Choudhary AK, Pretorius E. Revisiting the safety of aspartame, Nutrition Reviews, 75(9), 2017, Pages 718–730.
38Abrantes, Cátia G. et al. An Overview of Pharmaceutical Excipients: Safe or Not Safe? J Pharm Sciences 105:7:2019-2026.